Jupiter Neurosciences Showcases Nugevia™ PWR for Energy Boost
30 Jun 2025 //
GLOBENEWSWIRE
Jupiter Neurosciences Unveils Nugevia™ GLO for Skin Health
27 Jun 2025 //
GLOBENEWSWIRE
Jupiter Neurosciences Picks Annika Sörenstam as Ambassador
23 Jun 2025 //
GLOBENEWSWIRE
Jupiter Neurosciences Launches Nugevia™ Supplement Line
09 Jun 2025 //
GLOBENEWSWIRE
Jupiter Neurosciences Highlights Shareholder Letter Milestones
08 Apr 2025 //
GLOBENEWSWIRE
Jupiter, Aquanova Partner To Develop Longevity, Healthspan Products
04 Mar 2025 //
GLOBENEWSWIRE
Jupiter Neuro Focused on Advancing Clinical & Commercial Milestones
04 Feb 2025 //
GLOBENEWSWIRE
Jupiter Announces Jotrol Manufacturing Agree for Parkinson`s Trial
03 Feb 2025 //
GLOBENEWSWIRE
Jupiter Partners with Zina Bio to Advance Ph 2a Parkinson`s Trial
30 Jan 2025 //
GLOBENEWSWIRE
Jupiter Focuses On NLRP3 Pathway For Future Jotrol™ Trials
13 Jan 2025 //
GLOBENEWSWIRE
Jupiter Neuro Announces Closing of $11 M Initial Public Offering
04 Dec 2024 //
GLOBENEWSWIRE
Jupiter Neurosciences Prices $11M IPO, Lists On Nasdaq
02 Dec 2024 //
GLOBENEWSWIRE
Jupiter Neurosciences, Inc. Announces Appointment of New Chief Financial Officer
12 Jan 2023 //
PR NEWSWIRE